DJIA 18,154.08 73.94 0.41%
NASDAQ 5,115.02 22.93 0.45%
S&P 500 2,124.27 6.58 0.31%
market minute promo

Gilead Sciences (NASDAQ: GILD)

104.49 0.79 (0.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $104.49 0.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.18
Previous Close $103.70
Daily Range $103.63 - $104.53
52-Week Range $72.77 - $116.83
Market Cap $155.6B
P/E Ratio 14.11
Dividend (Yield) $0.00 (0.0%)
Volume 2,022,238
Average Daily Volume 11,047,001
Current FY EPS $10.18




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

Can You Guess Which State Won't Pay for Hepatitis C Drugs?

One state decided to take a hard line stance against Gilead's pricey hep C drugs last year. And this decision may end up turning into a huge windfall for AbbVie's rival therapy. Here's why.

Short Sellers Become More Wary of Big Biotech

3 'Safe' Biotech Picks

Why Healthcare is the Best Sector For Your Money

Our experts weigh in.

I Called It: What's The Take Home Message?

Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog

AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog

Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More

AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story

See More GILD News...

GILD's Top Competitors

GILD $104.49 (0.76%)
Current stock: GILD
AMGN $166.66 (-0.74%)
Current stock: AMGN
CELG $118.10 (-0.51%)
Current stock: CELG
$0.00 (0.00%)
Current stock: